Skip to main content
Signal8
Launch Terminal
Lynch Thomas J. Jr. profile photo

Thomas J. Lynch Jr.

CIK: 0001474056

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

Natera, Inc. logo
NTRA

Natera, Inc.

Director
Foghorn Therapeutics Inc. logo
FHTX

Foghorn Therapeutics Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • Natera, Inc. logo
    NTRA

    Natera, Inc.

    Jun 26, 2026
    Award(A)
    Direct
    1.9K shares-
  • Foghorn Therapeutics Inc. logo
    FHTX

    Foghorn Therapeutics Inc.

    Jun 24, 2026
    Award(A)

    Stock Options (Right to buy)

    Direct
    28K shares at avg. $4.08-
  • Foghorn Therapeutics Inc. logo
    FHTX

    Foghorn Therapeutics Inc.

    Jun 17, 2025
    Award(A)

    Stock Option (right to buy)

    Direct
    25K shares at avg. $4.79-

1-3 of 3

About Lynch Thomas J. Jr.

Lynch Thomas J. Jr. (SEC CIK 0001474056) files insider reports with the SEC as Director of Natera, Inc. (NTRA) and Director of Foghorn Therapeutics Inc. (FHTX).

Signal8 holds 4 ownership filings by Lynch Thomas J. Jr. (1 Form 3, 3 Form 4), filed between Jun 17, 2025 and Jun 30, 2026. Those filings report 3 transactions, from Jun 17, 2025 to Jun 26, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Lynch Thomas J. Jr.'s filings is in WATERTOWN, MA.

Recent filings by Lynch Thomas J. Jr.

  • Jun 26, 2026: Grant or award of NTRA shares (Form 4, code A).
  • Jun 24, 2026: Grant or award of FHTX derivative securities (Form 4, code A).
  • Jun 17, 2025: Grant or award of FHTX derivative securities (Form 4, code A).

Other insiders filing for Natera, Inc. (NTRA)

How to read Form 4 transaction codes